Selvita's (WSE:SLV) Solid Earnings May Rest On Weak Foundations
Apr 03
Polish (WIG) Healthcare Sector Analysis
UpdatedApr 17, 2024
DataAggregated Company Financials
Companies48
- 7D-0.09%
- 3M2.6%
- 1Y12.0%
- YTD2.7%
Over the last 7 days, the Healthcare industry has remained flat, although notably Selvita gained 5.2%. As for the the longer term, the industry is up 12% over the past 12 months. Looking forward, earnings are forecast to grow by 17% annually.
Sector Valuation and Performance
Has the Polish Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 17 Apr 2024 | zł14.9b | zł16.0b | -zł100,002,749.00 | 38.7x | -148.9x | 0.9x |
| Fri, 15 Mar 2024 | zł15.1b | zł16.0b | -zł218,743,549.00 | 40.8x | -69.3x | 0.9x |
| Sun, 11 Feb 2024 | zł14.6b | zł15.9b | -zł257,176,129.00 | 36.5x | -56.7x | 0.9x |
| Tue, 09 Jan 2024 | zł14.9b | zł15.9b | -zł245,263,080.00 | 32.2x | -60.6x | 0.9x |
| Thu, 07 Dec 2023 | zł14.4b | zł15.9b | zł94.7m | 29.2x | 152.4x | 0.9x |
| Sat, 04 Nov 2023 | zł13.4b | zł15.7b | zł110.2m | 31.1x | 121.4x | 0.9x |
| Mon, 02 Oct 2023 | zł13.5b | zł15.7b | zł94.0m | 27.4x | 143.4x | 0.9x |
| Wed, 30 Aug 2023 | zł14.3b | zł15.5b | zł103.2m | 22.7x | 138.2x | 0.9x |
| Fri, 28 Jul 2023 | zł14.3b | zł15.4b | zł101.1m | 25.1x | 141.3x | 0.9x |
| Sun, 25 Jun 2023 | zł14.5b | zł15.4b | zł123.0m | 26.5x | 117.6x | 0.9x |
| Tue, 23 May 2023 | zł14.0b | zł15.4b | zł192.7m | 25x | 72.7x | 0.9x |
| Thu, 20 Apr 2023 | zł13.4b | zł15.5b | zł257.9m | 27.1x | 51.9x | 0.9x |
| Sat, 18 Mar 2023 | zł13.5b | zł15.1b | zł259.2m | 26.9x | 52.1x | 0.9x |
| Mon, 13 Feb 2023 | zł13.3b | zł15.0b | zł237.8m | 26x | 55.8x | 0.9x |
| Wed, 11 Jan 2023 | zł13.5b | zł15.0b | zł237.9m | 26.2x | 56.9x | 0.9x |
| Fri, 09 Dec 2022 | zł12.6b | zł15.0b | zł232.4m | 26.5x | 54.4x | 0.8x |
| Sun, 06 Nov 2022 | zł12.1b | zł14.8b | -zł130,356,320.00 | 22.8x | -92.6x | 0.8x |
| Tue, 04 Oct 2022 | zł11.8b | zł14.8b | -zł117,425,044.00 | 22.2x | -100.3x | 0.8x |
| Thu, 01 Sep 2022 | zł12.5b | zł14.6b | zł259.2m | 20.6x | 48x | 0.9x |
| Sat, 30 Jul 2022 | zł12.6b | zł14.8b | zł265.8m | 20.8x | 47.5x | 0.9x |
| Mon, 27 Jun 2022 | zł11.5b | zł14.8b | zł265.8m | 17.2x | 43.4x | 0.8x |
| Wed, 25 May 2022 | zł12.6b | zł15.1b | zł549.7m | 22.9x | 22.9x | 0.8x |
| Fri, 22 Apr 2022 | zł14.7b | zł15.1b | zł843.1m | 23.4x | 17.4x | 1x |
| Sun, 20 Mar 2022 | zł14.9b | zł14.9b | zł900.7m | 23.3x | 16.6x | 1x |
| Tue, 15 Feb 2022 | zł15.3b | zł14.8b | zł936.0m | 26.3x | 16.4x | 1x |
| Thu, 13 Jan 2022 | zł17.6b | zł14.8b | zł930.7m | 25.4x | 18.9x | 1.2x |
| Sat, 11 Dec 2021 | zł16.9b | zł14.8b | zł929.1m | 24.1x | 18.2x | 1.1x |
| Mon, 08 Nov 2021 | zł18.3b | zł14.7b | zł1.3b | 32.1x | 14x | 1.2x |
| Wed, 06 Oct 2021 | zł17.6b | zł14.7b | zł1.3b | 30.4x | 13.4x | 1.2x |
| Fri, 03 Sep 2021 | zł18.7b | zł14.4b | zł1.4b | 31x | 13.1x | 1.3x |
| Sun, 01 Aug 2021 | zł18.6b | zł14.4b | zł1.4b | 30.2x | 13.1x | 1.3x |
| Wed, 05 May 2021 | zł18.7b | zł14.0b | zł1.4b | 32.7x | 13.3x | 1.3x |
Price to Earnings Ratio
13.3x
Current Industry PE
- Investors are relatively neutral on the Polish Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 1.00x.
Past Earnings Growth
- Total earnings for the Healthcare industry have declined over the last three years, with the industry now making a loss overall.
- Meanwhile revenues have grown 4.6% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Polish Healthcare sector?
| PL Market | -0.84% | |
| Healthcare | -0.088% | |
| Biotech | 2.20% | |
| Life Sciences | 2.14% | |
| Medical Equipment | 0.36% | |
| Healthcare Services | 0.24% | |
| Pharma | -2.82% | |
| Healthtech | -8.26% | |
Industry PE
- Investors are most optimistic about the Healthcare Services industry even though it's trading below its 3-year average PE ratio of 28.9x.
- Analysts are expecting annual earnings growth of 18.0%, which is lower than the prior year's growth of 53.3% per year.
Forecasted Growth
- Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 44% over the next 5 years.
- This is roughly in line with its past earnings growth rate.
- In contrast, the Life Sciences industry is expected to see its earnings growth to stay flat over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| SLV Selvita | zł71.00 | 5.2% +zł64.2m | -7.8% | PE18.7x | |
| VOX Voxel | zł95.20 | 3.5% +zł33.6m | 127.2% | PE12.4x | |
| CTX Captor Therapeutics Spolka Akcyjna | zł79.00 | 8.2% +zł27.9m | -52.1% | PS29.3x | |
| SVE Synthaverse | zł4.42 | 8.3% +zł24.0m | -28.7% | PE65.5x | |
| SCP Scope Fluidics | zł190.60 | 3.4% +zł16.9m | -2.3% | PS569.7x |